SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-17-185562
Filing Date
2017-05-26
Accepted
2017-05-26 16:15:03
Documents
7
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d366372d10qa.htm 10-Q/A 20862
2 EX-10.5 d366372dex105.htm EX-10.5 537777
3 EX-31.3 d366372dex313.htm EX-31.3 3869
4 EX-31.4 d366372dex314.htm EX-31.4 3808
5 GRAPHIC g366372g0523102615022.jpg GRAPHIC 2595
6 GRAPHIC g366372g0523120221480.jpg GRAPHIC 2076
7 GRAPHIC g366372g0523120221558.jpg GRAPHIC 1014
  Complete submission text file 0001193125-17-185562.txt   575771
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35238 | Film No.: 17874128
SIC: 2834 Pharmaceutical Preparations